Introduction:
It is a fully human recombinant monoclonal antibody (MAB).
Mechanism of action:
It gets bind to human TNF-α receptor site thus stops endogenous TNF- α activity by preventing its interaction with p55 and p75 cell surface receptors.
Action:
It decreases symptoms of Rheumatoid arthritis and stops erosion of the (bone) structure.
Therapeutic uses:
It is used in Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. (As increased TNF in the synovial fluid cause pain and joint destruction in Rheumatoid arthritis).
Pharmacokinetics:
It is used subcutaneously and its half life is 10-20 days.
Dose and Administration:
Its usual dose is 40 mg every other week. It is used Subcutaneously only.
Adverse effects:
It may cause headache, nausea, rashes and reactions at the site of injection.
-
Q: What do you know about ergot alkaloids? Ans: These include alkaloids which we get from the ergot fungus Claviceps purpurea or derived ...
-
(For detailed study of Pharmaceutical Incompatibility Click here) Multiple Choice Questions (MCQs) from Pharmaceutical Incompatibility in ...
-
Multiple Choice Questions (MCQs) of Powders and Granules from Pharmaceutics 1. _______ powders consist of more than one ingredients. a. Si...
No comments:
Post a Comment